Carl Runde

Carl Runde is a finance professional with over two decades of experience in the international medical device industry, specializing in corporate financial analysis, valuation modeling, and strategic business planning.

Having held key positions such as Chief Financial Officer at Atmo Biosciences, Vice President at ResMed, and Director at Osteopore Limited, Carl has demonstrated a track record of delivering value as a finance partner to various functions including commercial operations, research and development, human resources, and corporate strategy.

His academic background includes a PhD from the University of Sydney, an MBA from Macquarie Graduate School of Management, and Bachelor's degrees in International Relations, Economics, Economic History, Political Studies, English, and Law from the University of the Witwatersrand.

Carl Runde's expertise lies in driving inclusive approaches to sustainable growth and stakeholder value creation, aligning financial strategies with organizational objectives, and leveraging international practical knowledge to support business operations and decision-making.

With a rich professional history that spans leadership roles in finance and academia, Carl Runde combines theoretical insights with hands-on experience to make impactful contributions in the realms of financial management, strategic planning, and corporate governance.